Should Drugs Be Studied in More Patients Before Approval?

Researchers from Duke have a modest proposal to catch safety problems with new drugs: Study them in more people before they go to market. Playing what-if with computer models, Shelby Reed and her Duke colleagues found that doubling the size of a hypothetical study to include 4,000 patients in each group treated improved the chances [...]